Arne Skag

Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis

Charles H. Chesnut, Arne Skag, Claus Christiansen et al. · Journal of Bone and Mineral Research · 2004 · 1.2K citations · Full text

Medicine, Pharmacotherapy, Bone Augmentation +16

Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study

Pierre D. Delmas, Robert R. Recker, C. H. Chesnut et al. · Osteoporosis International · 2004 · 279 citations

Medicine, Endocrinology, Bone Metabolism +13

Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis

Robert R. Recker, J. A. Stakkestad, C. H. Chesnut et al. · Bone · 2004 · 173 citations

Medicine, Endocrinology, Pharmacotherapy +10

Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.

Mark P. Ettinger, Dieter Felsenberg, Steven T. Harris et al. · PubMed · 2005 · 21 citations

Medicine, Geriatric Medicine, Bone Metabolism +16

Risk factors for low bone mineral density among a large group of Norwegian women with fractures

Line M. Omland, Grethe S. Tell, Snorre Øfjord et al. · European Journal of Epidemiology · 2000 · 11 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17